For Sun Pharma, its investment in speciality business is paying off, as it is becoming a driver of growth for the company’s US business. Cipla’s ‘One India’ strategy, focusing on branded prescription, trade generics and consumer health brands, is leading to continued core portfolio momentum across businesses.
Bullish on Adani group? GQG raises stakes in 3 stocks even as FIIs cut back in market crash
GQG Partners, long bullish on the Adani group, modestly raised stakes in key companies during the March quarter despite mixed stock performance. It increased holdings